Pedro Farinha

Clinical Professor

The University of British Columbia

Canada

Research Interests

Explore related searches

Professors in Canada Professors in Immunology Immunology professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Pedro Farinha is a Clinical Professor at The University of British Columbia in Canada. His research focuses on high-grade B-cell lymphoma, specifically investigating genetic mutations and their implications in cancer treatment and prognosis. Recent publications include studies on metastatic patterns, precision oncology initiatives, and the impact of various genetic rearrangements in lymphoma outcomes.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Collaborators (18)

Laura Hilton

Adjunct Professor

Simon Fraser University

CANADA

Pedro Farinha

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

The Terry Fox Research Institute Marathon of Hope Cancer Centres Network: A pan-Canadian precision oncology initiative

High-grade B-cell lymphoma, not otherwise specified: an LLMPP study.

Somatic IRF4 Mutations and Thymic Tropism in Primary Mediastinal Large B-cell Lymphoma.

CNS relapse in high-grade B-cell lymphoma with MYC and BCL2 rearrangements and dark-zone signature–expressing DLBCL

The Impact of Scoring Method on Accuracy and Reproducibility of Hans Cell-of-Origin Prediction in Excisional Biopsies of Diffuse Large B-Cell Lymphoma, Not Otherwise Specified.

Unbalanced MYC break-apart FISH patterns indicate the presence of a MYC rearrangement in HGBCL-DH-BCL2.

Long-term follow-up of bulky classic Hodgkin lymphoma managed with ABVD and PET-guided RT demonstrates excellent outcomes in PET-negative cases.

Maximum disease diameter is associated with outcomes in stage II follicular lymphoma treated with radiation therapy alone.

Integrated single cell analysis reveals co-evolution of malignant B cells and tumor micro-environment in transformed follicular lymphoma.

Integrated single cell analysis reveals co-evolution of malignant B cells and tumor micro-environment in transformed follicular lymphoma.

Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748 (Leukemia, (2022), 36, 7, (1720-1748), 10.1038/s41375-022-01620-2)

Genetic subdivisions of follicular lymphoma defined by distinct coding and noncoding mutation patterns

Kikuchi-Fujimoto Disease Following COVID-19 Vaccination: Experience at a Population-Based Referral Center.

Relapse Timing Is Associated With Distinct Evolutionary Dynamics in Diffuse Large B-Cell Lymphoma.

Patterns of Oncogene Coexpression at Single-Cell Resolution Influence Survival in Lymphoma.

Patterns of Oncogene Coexpression at Single-Cell Resolution Influence Survival in Lymphoma

Lack of Reproducibility of Histopathological Features in MYC-rearranged Large B-cell Lymphoma Using Digital Whole Slide Images: A Study from the Lunenburg Lymphoma Biomarker Consortium.

A N(ew) MYC joins T-cell lymphomagenesis

The outcome of older adults with classic Hodgkin lymphoma in British Columbia

Molecular Determinants of Clinical Outcomes In a Real-World Diffuse Large B-cell Lymphoma Population.

Collaborators (18)

Laura Hilton

Kikkeri N Naresh

Javeed Iqbal

Yasodha Natkunam

David W. Scott

Mitchell Elliott

David Dix

Brian Walker

Catalina Amador

Anand D. Jeyasekharan

John Choi

Jennifer Chan

lucia nappi

Joon Seon Lee

Reuben M. Tooze

Sarah E. Coupland

Vaskar Saha

Darrell Underhill

Make your next move.